ArticleClinical kidney journal2026
Belatacept for calcineurin inhibitor-induced pain syndrome in a kidney transplant recipient.
Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Calcineurin inhibitor (CNI) pain syndrome is a rare but debilitating adverse effect of CNIs when used in kidney transplant recipients. The pain affects lower limbs and it is usually bilateral and symmetrical. All other causes of foot pain should be excluded before diagnosis. Treatment is not always successful and options are limited as the mainstay is either CNI withdrawal or dose reduction. The available treatments can compromise graft function and lead to reduced graft survival. Herein, we report a case of CNI pain syndrome in a kidney transplant recipient in which belatacept was used successfully. There was complete pain relief and regain of function in affected lower limb. The bone marrow edema also significantly improved on magnetic resonance imaging. Normal kidney functions were maintained on follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.